Delivery Order SPE2DB24D1104-SPE2DB25FYFG2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $18,874.86 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on August 20, 2025, with a completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $36,319.73 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count packages) on August 26, 2025, with completion scheduled for August 27, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $7,891.76 delivery order to AmerisourceBergen Drug Corp for Otezla 30 mg tablets (60-count) on June 20, 2025, with completion scheduled for June 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Otezla 30 mg tablets (60-count units) under a firm fixed-price contract valued at $21,053.19. The contract, with an ultimate completion date of August 28, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued against...
- The Defense Logistics Agency awarded a $1,311.62 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $12,445.76 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a $19,860.97 delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on June 26, 2025, with completion expected by June 27, 2025. This firm fixed-price contract represents a non-competitive set-aside and reflects AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal medical procurement needs. The order is being performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a $21,010.71 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Otezla 30 mg tablets (60-count). This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a $36,477.84 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Otezla 30 mg tablets (60-count units). The contract is a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $35,330.15 by the Defense Logistics Agency (DLA) on September 17, 2025, for the supply of Otezla 30 mg tablets (60-count units). This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYFG2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $18,324.62 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count) on September 3, 2025, with completion targeted for September 4, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies critical pharmaceutical products and medical commodities to support military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to deliver a comprehensive range of medications across multiple therapeutic domains, from specialty pharmaceuticals to vaccines and medical supplies. This particular delivery order for Otezla, a treatment commonly used for psoriatic arthritis and other conditions, exemplifies AmerisourceBergen's role as a key vendor within the Defense Health Agency's pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.3k | 9/3/25 |